跳至主要内容
临床试验/NCT03414177
NCT03414177已完成不适用

Telehealth Enhanced Asthma Management

Arkansas Children's Hospital Research Institute2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2018年3月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
2
主要终点
Mean difference in ACT score at the final assessment (12 months) after adjusting for baseline

研究概览

简要总结

This study will conduct a 12-month randomized trial with 48 pediatric patients (aged 6-18 years) with persistent asthma to compare outcomes among patients with follow-up visits managed via telemedicine (TM) vs. in-person (IP) visits.

详细描述

The overarching hypothesis is that utilization of TM for asthma follow-up will result in improved clinical outcomes such as Asthma Control Test (ACT) scores, lung function and medication adherence compared to participants receiving IP follow-up care. The Investigator also hypothesize that TM follow-up will result in higher caregiver satisfaction because families will be able to receive quality subspecialty care in their community (TM) compared to those who travel a distance to receive care (IP).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
6 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • age ≥6- and ≤18 years
  • persistent asthma as defined by national guidelines standards
  • receives care at an ACH asthma subspecialty clinic
  • reside ≤1.5 hour drive from Jonesboro, Springdale, Texarkana, or Fort Smith, AR

排除标准

  • Significant underlying respiratory disease other than asthma, such as cystic fibrosis
  • significant co-morbid conditions, such as individuals with developmental or physical impairments that could interfere with the ability to communicate via interactive video
  • current smoker
  • severe asthma exacerbation requiring intubation in the past 12 months
  • no access to a smartphone or internet

结局指标

主要结局

Mean difference in ACT score at the final assessment (12 months) after adjusting for baseline

时间窗: At baseline and 12 months

ACT is used for symptoms monitoring as per guidelines and has been identified as an appropriate asthma control composite score in clinical research.

次要结局

  • Airway Inflammation via Spirometry(Baseline and 12 months)
  • Healthcare Utilization(At baseline, 4 months, 8 months, 12 months)
  • Routine Follow up Asthma Visit(At baseline, 4 months, 8 months, 12 months)
  • Lung Function via Spirometry(Baseline and 12 months)
  • Medication Adherence(At baseline, 4 months, 8 months, 12 months)
  • Rescue Medication Use(At baseline, 4 months, 8 months, 12 months)
  • Clinic Visit Attendance Rate(At baseline, 4 months, 8 months, 12 months)
  • Visit Satisfaction(At baseline, 4 months, 8 months, 12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验